Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-25 @ 2:23 AM
NCT ID:
NCT05525234
Eligibility Criteria:
Inclusion Criteria:
* Maintenance hemodialysis patients (≥3 month), 3 times/week, 4 hours/session
* spKT/V≥1.2
* The diagnosis was refractory urmia pruritus and pruritus score ≥8 score
* Patients with sleep disorders need to stop sleeping pills
* Be able to complete the form by yourself or with the help of others
* Informed consent
Exclusion Criteria:
* Participants in other clinical trials within 1 month
* People with thalidomide allergy
* Accompanied by severe calcium and phosphorus metabolism disorder (serum calcium≥3.0mmol/L or Serum phosphorus≥2.8mmol/L or Serum iPTH≥800pg/mL)
* Patients with other medical conditions that cause itchy skin
* With severe systemic infection, severe anemia and other serious complications
* Patients with peripheral neuropathy
* Other serious systemic diseases include systemic lupus erythematosus, multiple myeloma, thrombotic microangiopathy, and extensive metastasis of malignant tumors
* Patients with a history of thromboembolism were excluded from PICC-induced thrombosis
* Pregnant woman
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05525234
Study Brief:
Protocol Section:
NCT05525234